Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05890677 · ClinicalTrials.gov registry record · NA
The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
A NA study of Lymphedema, Breast Cancer, sponsored by University Hospital, Basel, Switzerland.
- Recruiting
- Registry status
- NA
- Development phase
- 280
- Enrollment target
- 20
- Study locations
NCT05890677 is a NA study of Lymphedema, Breast Cancer that is actively recruiting participants, run by University Hospital, Basel, Switzerland. The registered enrollment target is 280 participants. The trial reports 20 study locations across 7 states.
The verdict
NCT05890677, a NA study of Lymphedema, Breast Cancer, is actively recruiting participants, sponsored by University Hospital, Basel, Switzerland.
- RECRUITING
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
- 20
- Study locations
Study Summary
The aim of this study is to test whether lymphatic surgery provides better QoL (assessed with the Lymph-ICF-UL, (Lymphedema Functioning Disability and health questionnaire for upper limb lymphedema)) 15 months after randomization (and therefore about one year after surgery) compared to conservative treatment only for patients with chronic lymphedema (LE)
Conditions Studied
Interventions
- PROCEDURE Surgical Intervention
- PROCEDURE Conservative Complex Physical Decongestion Therapy
Study Locations (20)
Other
- Krankenhaus Göttlicher Heiland GmbH - Vienna
- University of Ghent - Ghent
- McGill University, Royal Victoria Hospital - Montreal
- University of British Columbia, Gordon and Leslie Diamond Health Care Centre - Vancouver
- BG Universitätsklinikum Bergmannsheil Bochum - Bochum
- Sana Kliniken Düsseldorf - Düsseldorf
- Uniklinikum Erlangen - Erlangen
- KEM Evang. Kliniken Essen-Mitte - Essen
- BG Klinik Frankfurt am Main - Frankfurt
- Universitätsklinikum Freiburg, Klinik für Plastische und Handchirurgie - Freiburg im Breisgau
- BG Klinik Ludwigshafen - Ludwigshafen am Rhein
- Klinikum Nürnberg - Nuremberg
- Caritas Krankenhaus St. Josef/ Uniklinik Regensburg - Regensburg
- Papageorgiou Hospital of Thessaloniki - Thessaloniki
Connecticut
- Yale School of Medicine - New Haven
Massachusetts
- Harvard Medical School - Boston
Missouri
- Washington University School of Medicine in St. Louis - St Louis
New York
- Mayo Clinic - Rochester
Jette
- Brussels University Hospital - Brussels
Curitiba
- Hospital Erasto Gaertner - Paraná
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2023-07-14 |
| Est. Completion | 2036-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05890677
The ClinicalTrials.gov registry entry for NCT05890677 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospital, Basel, Switzerland, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lymphedema, Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Surgical Intervention is the first listed.
NCT05890677 reports 20 study locations spanning 7 distinct geographic areas - top geographies include Other, Connecticut, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05890677 about?
NCT05890677 is a clinical study titled "The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema". The aim of this study is to test whether lymphatic surgery provides better QoL (assessed with the Lymph-ICF-UL, (Lymphedema Functioning Disability and health questionnaire for upper limb lymphedema)) 15 months after randomization (and therefore about one year after surgery) compared to conservative ...
What is the current status of trial NCT05890677?
This trial is currently recruiting. It is a NA study. The enrollment target is 280 participants. The study started on 2023-07-14. Estimated completion is 2036-06.
What conditions does trial NCT05890677 study?
This clinical trial studies the following conditions: Lymphedema, Breast Cancer.
What interventions are being tested in trial NCT05890677?
The interventions under investigation include: Surgical Intervention (PROCEDURE), Conservative Complex Physical Decongestion Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT05890677?
This trial is sponsored by University Hospital, Basel, Switzerland, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05890677 being conducted?
This trial has 20 study locations across Connecticut, Massachusetts, Missouri, New York, Jette. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphedema, Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.